Cargando…

Proteomic characterisations of ulcerative colitis endoscopic biopsies associate with clinically relevant histological measurements of disease severity

AIMS AND METHODS: Accurate protein measurements using formalin-fixed biopsies are needed to improve disease characterisation. This feasibility study used targeted and global mass spectrometry (MS) to interrogate a spectrum of disease severities using 19 ulcerative colitis (UC) biopsies. RESULTS: Tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Gruver, Aaron M, Westfall, Matt D, Ackermann, Bradley L, Hill, Salisha, Morrison, Ryan D, Bodo, Juraj, Lai, Keith K, Gemperline, David C, Hsi, Eric D, Liebler, Daniel C, Schmitz, Jochen, Benschop, Robert J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411881/
https://www.ncbi.nlm.nih.gov/pubmed/34353876
http://dx.doi.org/10.1136/jclinpath-2021-207718
_version_ 1784775364681138176
author Gruver, Aaron M
Westfall, Matt D
Ackermann, Bradley L
Hill, Salisha
Morrison, Ryan D
Bodo, Juraj
Lai, Keith K
Gemperline, David C
Hsi, Eric D
Liebler, Daniel C
Schmitz, Jochen
Benschop, Robert J
author_facet Gruver, Aaron M
Westfall, Matt D
Ackermann, Bradley L
Hill, Salisha
Morrison, Ryan D
Bodo, Juraj
Lai, Keith K
Gemperline, David C
Hsi, Eric D
Liebler, Daniel C
Schmitz, Jochen
Benschop, Robert J
author_sort Gruver, Aaron M
collection PubMed
description AIMS AND METHODS: Accurate protein measurements using formalin-fixed biopsies are needed to improve disease characterisation. This feasibility study used targeted and global mass spectrometry (MS) to interrogate a spectrum of disease severities using 19 ulcerative colitis (UC) biopsies. RESULTS: Targeted assays for CD8, CD19, CD132 (interleukin-2 receptor subunit gamma/common cytokine receptor gamma chain), FOXP3 (forkhead box P3) and IL17RA (interleukin 17 receptor A) were successful; however, assays for IL17A (interleukin 17A), IL23 (p19) (interleukin 23, alpha subunit p19) and IL23R (interleukin 23 receptor) did not permit target detection. Global proteome analysis (4200 total proteins) was performed to identify pathways associated with UC progression. Positive correlation was observed between histological scores indicating active colitis and neutrophil-related measurements (R(2)=0.42–0.72); inverse relationships were detected with cell junction targets (R(2)=0.49–0.71) and β-catenin (R(2)=0.51–0.55) attributed to crypt disruption. An exploratory accuracy assessment with Geboes Score and Robarts Histopathology Index cut-offs produced sensitivities/specificities of 72.7%/75.0% and 100.0%/81.8%, respectively. CONCLUSIONS: Pathologist-guided MS assessments provide a complementary approach to histological scoring systems. Additional studies are indicated to verify the utility of this novel approach.
format Online
Article
Text
id pubmed-9411881
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-94118812022-09-12 Proteomic characterisations of ulcerative colitis endoscopic biopsies associate with clinically relevant histological measurements of disease severity Gruver, Aaron M Westfall, Matt D Ackermann, Bradley L Hill, Salisha Morrison, Ryan D Bodo, Juraj Lai, Keith K Gemperline, David C Hsi, Eric D Liebler, Daniel C Schmitz, Jochen Benschop, Robert J J Clin Pathol Short Report AIMS AND METHODS: Accurate protein measurements using formalin-fixed biopsies are needed to improve disease characterisation. This feasibility study used targeted and global mass spectrometry (MS) to interrogate a spectrum of disease severities using 19 ulcerative colitis (UC) biopsies. RESULTS: Targeted assays for CD8, CD19, CD132 (interleukin-2 receptor subunit gamma/common cytokine receptor gamma chain), FOXP3 (forkhead box P3) and IL17RA (interleukin 17 receptor A) were successful; however, assays for IL17A (interleukin 17A), IL23 (p19) (interleukin 23, alpha subunit p19) and IL23R (interleukin 23 receptor) did not permit target detection. Global proteome analysis (4200 total proteins) was performed to identify pathways associated with UC progression. Positive correlation was observed between histological scores indicating active colitis and neutrophil-related measurements (R(2)=0.42–0.72); inverse relationships were detected with cell junction targets (R(2)=0.49–0.71) and β-catenin (R(2)=0.51–0.55) attributed to crypt disruption. An exploratory accuracy assessment with Geboes Score and Robarts Histopathology Index cut-offs produced sensitivities/specificities of 72.7%/75.0% and 100.0%/81.8%, respectively. CONCLUSIONS: Pathologist-guided MS assessments provide a complementary approach to histological scoring systems. Additional studies are indicated to verify the utility of this novel approach. BMJ Publishing Group 2022-09 2021-08-05 /pmc/articles/PMC9411881/ /pubmed/34353876 http://dx.doi.org/10.1136/jclinpath-2021-207718 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Short Report
Gruver, Aaron M
Westfall, Matt D
Ackermann, Bradley L
Hill, Salisha
Morrison, Ryan D
Bodo, Juraj
Lai, Keith K
Gemperline, David C
Hsi, Eric D
Liebler, Daniel C
Schmitz, Jochen
Benschop, Robert J
Proteomic characterisations of ulcerative colitis endoscopic biopsies associate with clinically relevant histological measurements of disease severity
title Proteomic characterisations of ulcerative colitis endoscopic biopsies associate with clinically relevant histological measurements of disease severity
title_full Proteomic characterisations of ulcerative colitis endoscopic biopsies associate with clinically relevant histological measurements of disease severity
title_fullStr Proteomic characterisations of ulcerative colitis endoscopic biopsies associate with clinically relevant histological measurements of disease severity
title_full_unstemmed Proteomic characterisations of ulcerative colitis endoscopic biopsies associate with clinically relevant histological measurements of disease severity
title_short Proteomic characterisations of ulcerative colitis endoscopic biopsies associate with clinically relevant histological measurements of disease severity
title_sort proteomic characterisations of ulcerative colitis endoscopic biopsies associate with clinically relevant histological measurements of disease severity
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411881/
https://www.ncbi.nlm.nih.gov/pubmed/34353876
http://dx.doi.org/10.1136/jclinpath-2021-207718
work_keys_str_mv AT gruveraaronm proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity
AT westfallmattd proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity
AT ackermannbradleyl proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity
AT hillsalisha proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity
AT morrisonryand proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity
AT bodojuraj proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity
AT laikeithk proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity
AT gemperlinedavidc proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity
AT hsiericd proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity
AT lieblerdanielc proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity
AT schmitzjochen proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity
AT benschoprobertj proteomiccharacterisationsofulcerativecolitisendoscopicbiopsiesassociatewithclinicallyrelevanthistologicalmeasurementsofdiseaseseverity